The path of uncovering a prothrombotic thrombocytopenic syndrome after viral vector‐based COVID‐19 vaccination: Where there is much light, the shadow is deep
Guardado en:
Autores principales: | Johannes Thaler, Cihan Ay, Paul Knoebl |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c4400bc0014c45e1aa2cd1c0424e7004 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
por: Flora Peyvandi, et al.
Publicado: (2021) -
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
por: Barış YILMAZ, et al.
Publicado: (2021) -
COVID-19 and thrombotic thrombocytopenic purpura: A review of literature
por: Balraj Singh, et al.
Publicado: (2021) -
Hungry megakaryocytes on the hunt? An unusual case of extensive megakaryocyte emperipolesis
por: S. Vijaya Devi, et al.
Publicado: (2021) -
DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
por: Waail Rozi, et al.
Publicado: (2021)